Zhang et al. [15] have shown that transgenic Tg APP/PS1 mice, a model for Alzheimer’s disease, show increased levels of IL-1β in hippocampus and cognitive impairment. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.